Murray Alzheimer Research and Education Program (MAREP)
Alzheimer's disease and related dementias are a world-wide phenomenon that ignores social class and national boundaries. As age is the greatest risk factor for the development of Alzheimer's disease, more and more individuals will be diagnosed with Alzheimer's disease and related dementias as the population ages.
At the present time there is no known cause or cure for Alzheimer's disease. As the search for an effective treatment continues, it is important that people who have Alzheimer's disease or a related dementia receive the best care possible and are provided with support and opportunities to live meaningful lives.
To implement effective approaches for care of people living with Alzheimer's disease and related dementias, contemporary research findings need to be brought to the attention of all partners in care including people with dementia, family members and friends, health care professionals, and so forth. The converse is true as well in that effective approaches to care need to be brought to the attention of researchers.
The Murray Alzheimer Research and Education Program (MAREP) is an innovative program that adopts a partnership approach and integrates research and educational activities in an effort to improve dementia care practices in Canada and around the world. Although MAREP's research projects are funded by research grants, all of its knowledge translation activities are funded through donations and charitable gifts from individuals and groups. Learn how you can support our programs.
- June 26, 2017
The latest national dementia data from the Canadian Chronic Disease Surveillance System (CCDSS) was released this week. These data inform us that over 402,000 older adults in Canada are living with dementia; 76,000 new diagnoses are made every year; and 2 out of 3 Canadians living with dementia are female. This new information set illustrates dementia prevalence across gender, age, and geographic location, as well as indicating the impact the disease has on society; the government will use these data to inform Bill C-233, the national dementia strategy.
- June 26, 2017
This week, Bill C-233, an act respecting a national strategy for Alzheimer’s disease and other dementias, was passed. Canada will be implementing a national dementia strategy that will take into account the high prevalence, medical needs, and financial impact of the disease. The bill was co-sponsored by the Honourable Rob Oliphant, Don Valley West MP, and Rob Nicholson, Niagara Falls MP, along with the Standing Senate Committee on Social Affairs, Science, and Technology.
- June 26, 2017
A recent survey of American ‘baby boomers,’ or adults aged 53-71, discovered that 43% of these individuals either manage or assist in managing finances for an aging parent; almost two thirds (28%) of these people help with this management and 15% take full responsibility. Likelihood of managing or helping to manage parents’ finances increases with age. Most baby boomers become involved because of a sense of obligation and/or being asked for assistance.
- June 6, 2017
Hi I am your assignment for today.
- May 2, 2017
A Letter from the Chair
Hello, ODAG Members, Friends, and Supporters.
The last two months have been very interesting for people living with dementia. It is a time of policy changes, budget allocations and the broadening of the Council of Canadians with Disabilities to formally include people living with dementia.
- May 1, 2017
For many people living with dementia, our partners and supporters, the Ontario budget 2017 was a great success for us. When ODAG formed in the Fall of 2014, the original Board Members decided to create a group that would focus on creating a loud single voice of those living in Ontario who are living with dementia; and to do this through applying pressure on the government to create and fund a provincial strategy. I'm so pleased to say that we have won a huge win with allocation of money for this important plan.